Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Shrinking team NBB
FTE fell two years in a row, from 13 to 8.
-
Busy address KBO
18 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
PLASMA PROTEIN THERAPEUTICS ASSOCIATION EUROPE from Sint-Lambrechts-Woluwe, company number BE0453837462, closed financial year 2025 with a result of € 94,990 after tax. For that financial year PLASMA PROTEIN THERAPEUTICS ASSOCIATION EUROPE recorded revenue of € 3.4 million and equity of € 865,472. Compared with financial year 2024, the result moved from € -24,937 to € 94,990. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 11, 2026.
€ 865,472
▲ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 94,990
▲ still € 24,937 loss in 2024
Profit after tax over the fiscal year.
€ 1 million
▲ 1% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
8
▼ 2.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1.5 million
▼ 20% vs 2024
€ 189,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 38,404
▼ 46% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 8 days on average.
€ 444,477
▲ 3% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 3,898,866 | € 5,099,433 | € 3,438,677 | € 3,386,338 | ▼ 2% |
| Profit after taxes | € -156,549 | € 454,544 | € -24,937 | € 94,990 | ▲ € 119,927 |
| Equity | € 337,797 | € 795,419 | € 770,482 | € 865,472 | ▲ 12% |
| Total debts | € 802,001 | € 967,348 | € 714,067 | € 852,290 | ▲ 19% |
| Cash | € 714,947 | € 1,065,067 | € 1,017,849 | € 1,024,772 | ▲ 1% |
| Retained profit | € 337,797 | € 795,419 | € 770,482 | € 865,472 | ▲ 12% |
| Balance sheet total | € 1,139,798 | € 1,762,766 | € 1,484,549 | € 1,717,763 | ▲ 16% |
| Employees (FTE) | 10 | 13 | 10.5 | 8 | ▼ 2.5 |
Key figures of PLASMA PROTEIN THERAPEUTICS ASSOCIATION EUROPE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PLASMA PROTEIN THERAPEUTICS ASSOCIATION EUROPE?
What happened at PLASMA PROTEIN THERAPEUTICS ASSOCIATION EUROPE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 94,990. Source: NBB ↗
- New establishment in Sint-Lambrechts-Woluwe. KBO
- Start of the company according to the CBE. KBO
In short
From € 156,549 loss in 2022 to € 94,990 profit in 2025.
Best year ever: 2023, with € 454,544 profit.
Pays suppliers within 8 days on average.
A new publication or filing at PLASMA PROTEIN THERAPEUTICS ASSOCIATION EUROPE? We notify you, reason included.
Follow PLASMA PROTEIN THERAPEUTICS ASSOCIATION EUROPEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PLASMA PROTEIN THERAPEUTICS ASSOCIATION EUROPE are DAVID BELL, GILES PLATFORD and PAOLO MARCUCCI.
Directors
According to the 2025 annual accounts
DAVID BELL
Director
GILES PLATFORD
Director
PAOLO MARCUCCI
Director
Establishments
Establishment units
Physical locations of this company
Brand Whitlocklaan 114 box 4
1200 Sint-Lambrechts-Woluwe
Brand Whitlocklaan 114
1200 Sint-Lambrechts-Woluwe
Active since 1 January 2015
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 18 companies are registered at this address.
All companies at this address →L'appareil à Comptabiliser SAS
A. VAN INGELGEM ET FILS
€ 3.2 million gross margin · 2025
CAPIMMO
BUSTER
EPIMMO
€ -56,627 gross margin · 2024
+13 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0453.837.462
- VAT number
- BE 0453.837.462
- Registered office
- Brand Whitlocklaan 114 bus 4, 1200 Sint-Lambrechts-Woluwe
- Names & denominations
- PLASMA PROTEIN THERAPEUTICS ASSOCIATION EUROPE · PPTA EUROPE
- Enterprise type
- Rechtspersoon
- Legal form
- International non-profit association
- Legal situation
- Normale toestand
- Start date
- 7 November 1994
- Peppol
- Active · Active since 8 Dec 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Activiteiten op het gebied van voeding
Overige activiteiten i.v.m. gezondheidszorg, n.e.g.
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Overige menselijke gezondheidszorg, n.e.g.